Stephan Matthaei
Quakenbrueck, NI, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Gaps and barriers in the control of blood glucose in people with type 2 diabetes.
Journal: Diabetes & vascular disease research
Published: May 04, 2017
One-year efficacy and safety of saxagliptin add-on in patients receiving dapagliflozin and metformin.
Journal: Diabetes, obesity & metabolism
Published: April 20, 2016
Randomized, Double-Blind Trial of Triple Therapy With Saxagliptin Add-on to Dapagliflozin Plus Metformin in Patients With Type 2 Diabetes.
Journal: Diabetes care
Published: April 16, 2015
Durability and tolerability of dapagliflozin over 52 weeks as add-on to metformin and sulphonylurea in type 2 diabetes.
Journal: Diabetes, obesity & metabolism
Published: March 06, 2015
Dapagliflozin improves glycemic control and reduces body weight as add-on therapy to metformin plus sulfonylurea: a 24-week randomized, double-blind clinical trial.
Journal: Diabetes care
Published: January 17, 2015
Type 2 diabetes and cancer: should we prefer antihyperglycaemic treatments without unnecessarily increasing insulin levels?
Journal: Diabetes & vascular disease research
Published: September 25, 2014
Canagliflozin monotherapy: clinical study data in type 2 diabetes mellitus
Journal: Deutsche medizinische Wochenschrift (1946)
Published: February 01, 2014
Resource use and costs of exenatide bid or insulin in clinical practice: the European CHOICE study.
Journal: ClinicoEconomics and outcomes research : CEOR
Published: July 23, 2013
Individualized glycaemic targets and pharmacotherapy in type 2 diabetes.
Journal: Diabetes & vascular disease research
Published: May 29, 2013
Treatment outcomes after initiation of exenatide twice daily or insulin in clinical practice: 12-month results from CHOICE in six European countries.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: April 25, 2013
Using Exenatide Twice Daily or Insulin in Clinical Practice: Results from CHOICE.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: February 20, 2013
Patient-reported outcomes among patients using exenatide twice daily or insulin in clinical practice in six European countries: the CHOICE prospective observational study.
Journal: Health and quality of life outcomes
Published: February 19, 2013
Last Updated: 09/26/2026